Genetic  ||| S:0 E:8 ||| JJ
diversity  ||| S:8 E:18 ||| NN
and  ||| S:18 E:22 ||| CC
effect  ||| S:22 E:29 ||| NN
of  ||| S:29 E:32 ||| IN
natural  ||| S:32 E:40 ||| JJ
selection  ||| S:40 E:50 ||| NN
at  ||| S:50 E:53 ||| IN
apical  ||| S:53 E:60 ||| FW
membrane  ||| S:60 E:69 ||| FW
antigen-1  ||| S:69 E:79 ||| FW
( ||| S:79 E:80 ||| -LRB-
AMA-1 ||| S:80 E:85 ||| NNP
)  ||| S:85 E:87 ||| -RRB-
among  ||| S:87 E:93 ||| IN
Iranian  ||| S:93 E:101 ||| NNP
Plasmodium  ||| S:101 E:112 ||| NNP
vivax  ||| S:112 E:118 ||| FW
isolates  ||| S:118 E:127 ||| FW
Apical  ||| S:127 E:134 ||| FW
membrane  ||| S:134 E:143 ||| FW
antigen-1  ||| S:143 E:153 ||| FW
( ||| S:153 E:154 ||| -LRB-
AMA-1 ||| S:154 E:159 ||| NNP
)  ||| S:159 E:161 ||| -RRB-
of  ||| S:161 E:164 ||| IN
Plasmodium  ||| S:164 E:175 ||| NNP
vivax  ||| S:175 E:181 ||| FW
Grassi  ||| S:181 E:188 ||| FW
et  ||| S:188 E:191 ||| FW
Feletti ||| S:191 E:198 ||| NNP
,  ||| S:198 E:200 ||| ,
1890  ||| S:200 E:205 ||| CD
is  ||| S:205 E:208 ||| VBZ
a  ||| S:208 E:210 ||| DT
promising  ||| S:210 E:220 ||| JJ
malaria  ||| S:220 E:228 ||| JJ
vaccine  ||| S:228 E:236 ||| NN
candidate ||| S:236 E:245 ||| NN
.  ||| S:245 E:247 ||| .
However ||| S:247 E:254 ||| RB
,  ||| S:254 E:256 ||| ,
antigenic  ||| S:256 E:266 ||| JJ
variation  ||| S:266 E:276 ||| NN
is  ||| S:276 E:279 ||| VBZ
a  ||| S:279 E:281 ||| DT
major  ||| S:281 E:287 ||| JJ
problem  ||| S:287 E:295 ||| NN
to  ||| S:295 E:298 ||| TO
design  ||| S:298 E:305 ||| VB
a  ||| S:305 E:307 ||| DT
universal  ||| S:307 E:317 ||| JJ
malaria  ||| S:317 E:325 ||| JJ
vaccine ||| S:325 E:332 ||| NN
.  ||| S:332 E:334 ||| .
Hence ||| S:334 E:339 ||| RB
,  ||| S:339 E:341 ||| ,
detailed  ||| S:341 E:350 ||| JJ
understanding  ||| S:350 E:364 ||| NN
of  ||| S:364 E:367 ||| IN
the  ||| S:367 E:371 ||| DT
pvama-1  ||| S:371 E:379 ||| JJ
gene  ||| S:379 E:384 ||| NN
polymorphism  ||| S:384 E:397 ||| NNS
can  ||| S:397 E:401 ||| MD
provide  ||| S:401 E:409 ||| VB
conductive  ||| S:409 E:420 ||| JJ
information  ||| S:420 E:432 ||| NN
on  ||| S:432 E:435 ||| IN
this  ||| S:435 E:440 ||| DT
potential  ||| S:440 E:450 ||| JJ
vaccine  ||| S:450 E:458 ||| NN
component ||| S:458 E:467 ||| NN
.  ||| S:467 E:469 ||| .
Therefore ||| S:469 E:478 ||| RB
,  ||| S:478 E:480 ||| ,
this  ||| S:480 E:485 ||| DT
study  ||| S:485 E:491 ||| NN
investigated  ||| S:491 E:504 ||| VBD
the  ||| S:504 E:508 ||| DT
extent  ||| S:508 E:515 ||| NN
of  ||| S:515 E:518 ||| IN
genetic  ||| S:518 E:526 ||| JJ
polymorphisms  ||| S:526 E:540 ||| NN
at  ||| S:540 E:543 ||| IN
domain  ||| S:543 E:550 ||| NN
I  ||| S:550 E:552 ||| PRP
( ||| S:552 E:553 ||| -LRB-
DI ||| S:553 E:555 ||| NNP
) ||| S:555 E:556 ||| -RRB-
,  ||| S:556 E:558 ||| ,
DII  ||| S:558 E:562 ||| NNP
and  ||| S:562 E:566 ||| CC
partial  ||| S:566 E:574 ||| JJ
DIII  ||| S:574 E:579 ||| NN
of  ||| S:579 E:582 ||| IN
AMA-1  ||| S:582 E:588 ||| CD
among  ||| S:588 E:594 ||| IN
Iranian  ||| S:594 E:602 ||| NNP
P.  ||| S:602 E:605 ||| NNP
vivax  ||| S:605 E:611 ||| FW
isolates ||| S:611 E:619 ||| FW
.  ||| S:619 E:621 ||| .
Out  ||| S:621 E:625 ||| RB
of  ||| S:625 E:628 ||| IN
107  ||| S:628 E:632 ||| CD
blood  ||| S:632 E:638 ||| NN
samples ||| S:638 E:645 ||| NNS
,  ||| S:645 E:647 ||| ,
92  ||| S:647 E:650 ||| CD
were  ||| S:650 E:655 ||| VBD
analysed  ||| S:655 E:664 ||| VBN
based  ||| S:664 E:670 ||| VBN
on  ||| S:670 E:673 ||| IN
the  ||| S:673 E:677 ||| DT
quality  ||| S:677 E:685 ||| NN
of  ||| S:685 E:688 ||| IN
the  ||| S:688 E:692 ||| DT
sequencing  ||| S:692 E:703 ||| JJ
data ||| S:703 E:707 ||| NNS
.  ||| S:707 E:709 ||| .
The  ||| S:709 E:713 ||| DT
sequences  ||| S:713 E:723 ||| NN
were  ||| S:723 E:728 ||| VBD
classified  ||| S:728 E:739 ||| VBN
into  ||| S:739 E:744 ||| IN
53  ||| S:744 E:747 ||| CD
haplotypes ||| S:747 E:757 ||| NNS
.  ||| S:757 E:759 ||| .
Amino  ||| S:759 E:765 ||| JJ
acid  ||| S:765 E:770 ||| NN
changes  ||| S:770 E:778 ||| NNS
were  ||| S:778 E:783 ||| VBD
observed  ||| S:783 E:792 ||| VBN
at  ||| S:792 E:795 ||| IN
31  ||| S:795 E:798 ||| CD
positions  ||| S:798 E:808 ||| NNS
that  ||| S:808 E:813 ||| IN
17  ||| S:813 E:816 ||| CD
were  ||| S:816 E:821 ||| VBD
located  ||| S:821 E:829 ||| VBN
at  ||| S:829 E:832 ||| IN
DI ||| S:832 E:834 ||| NNP
,  ||| S:834 E:836 ||| ,
11  ||| S:836 E:839 ||| CD
were  ||| S:839 E:844 ||| VBD
at  ||| S:844 E:847 ||| IN
DII  ||| S:847 E:851 ||| NNP
and  ||| S:851 E:855 ||| CC
the  ||| S:855 E:859 ||| DT
rest  ||| S:859 E:864 ||| NN
of  ||| S:864 E:867 ||| IN
them  ||| S:867 E:872 ||| PRP
( ||| S:872 E:873 ||| -LRB-
3  ||| S:873 E:875 ||| CD
positions ||| S:875 E:884 ||| NNS
)  ||| S:884 E:886 ||| -RRB-
were  ||| S:886 E:891 ||| VBD
at  ||| S:891 E:894 ||| IN
DIII ||| S:894 E:898 ||| NNP
.  ||| S:898 E:900 ||| .
Thus ||| S:900 E:904 ||| RB
,  ||| S:904 E:906 ||| ,
codon  ||| S:906 E:912 ||| JJ
polymorphisms  ||| S:912 E:926 ||| NN
at  ||| S:926 E:929 ||| IN
DI  ||| S:929 E:932 ||| NNP
were  ||| S:932 E:937 ||| VBD
found  ||| S:937 E:943 ||| VBN
to  ||| S:943 E:946 ||| TO
be  ||| S:946 E:949 ||| VB
higher  ||| S:949 E:956 ||| JJR
than  ||| S:956 E:961 ||| IN
DII ||| S:961 E:964 ||| NNP
.  ||| S:964 E:966 ||| .
Also ||| S:966 E:970 ||| RB
,  ||| S:970 E:972 ||| ,
five  ||| S:972 E:977 ||| CD
of  ||| S:977 E:980 ||| IN
these  ||| S:980 E:986 ||| DT
polymorphic  ||| S:986 E:998 ||| JJ
codons  ||| S:998 E:1005 ||| NNS
( ||| S:1005 E:1006 ||| -LRB-
D242E ||| S:1006 E:1011 ||| NNP
,  ||| S:1011 E:1013 ||| ,
T374P ||| S:1013 E:1018 ||| NNP
,  ||| S:1018 E:1020 ||| ,
S389R ||| S:1020 E:1025 ||| NNP
,  ||| S:1025 E:1027 ||| ,
Y391F ||| S:1027 E:1032 ||| NNP
,  ||| S:1032 E:1034 ||| ,
I395F ||| S:1034 E:1039 ||| CD
)  ||| S:1039 E:1041 ||| -RRB-
were  ||| S:1041 E:1046 ||| VBD
novel  ||| S:1046 E:1052 ||| NN
and  ||| S:1052 E:1056 ||| CC
have  ||| S:1056 E:1061 ||| VBP
not  ||| S:1061 E:1065 ||| RB
been  ||| S:1065 E:1070 ||| VBN
reported  ||| S:1070 E:1079 ||| VBN
yet ||| S:1079 E:1082 ||| RB
.  ||| S:1082 E:1084 ||| .
Neutrality  ||| S:1084 E:1095 ||| JJ
analysis  ||| S:1095 E:1104 ||| NN
by  ||| S:1104 E:1107 ||| IN
using  ||| S:1107 E:1113 ||| VBG
the  ||| S:1113 E:1117 ||| DT
dN-dS  ||| S:1117 E:1123 ||| JJ
difference  ||| S:1123 E:1134 ||| NN
( ||| S:1134 E:1135 ||| -LRB-
the  ||| S:1135 E:1139 ||| DT
difference  ||| S:1139 E:1150 ||| NN
between  ||| S:1150 E:1158 ||| IN
the  ||| S:1158 E:1162 ||| DT
rate  ||| S:1162 E:1167 ||| NN
of  ||| S:1167 E:1170 ||| IN
non-synonymous  ||| S:1170 E:1185 ||| JJ
and  ||| S:1185 E:1189 ||| CC
synonymous  ||| S:1189 E:1200 ||| JJ
mutations ||| S:1200 E:1209 ||| NNS
)  ||| S:1209 E:1211 ||| -RRB-
showed  ||| S:1211 E:1218 ||| VBD
a  ||| S:1218 E:1220 ||| DT
negative  ||| S:1220 E:1229 ||| JJ
diversifying  ||| S:1229 E:1242 ||| JJ
selection  ||| S:1242 E:1252 ||| NN
at  ||| S:1252 E:1255 ||| IN
DI ||| S:1255 E:1257 ||| NNP
,  ||| S:1257 E:1259 ||| ,
DII  ||| S:1259 E:1263 ||| NNP
and  ||| S:1263 E:1267 ||| CC
across  ||| S:1267 E:1274 ||| IN
the  ||| S:1274 E:1278 ||| DT
length  ||| S:1278 E:1285 ||| NN
of  ||| S:1285 E:1288 ||| IN
both  ||| S:1288 E:1293 ||| DT
domains ||| S:1293 E:1300 ||| NN
.  ||| S:1300 E:1302 ||| .
The  ||| S:1302 E:1306 ||| DT
potential  ||| S:1306 E:1316 ||| JJ
B-cell  ||| S:1316 E:1323 ||| JJ
epitopes  ||| S:1323 E:1332 ||| NN
were  ||| S:1332 E:1337 ||| VBD
found  ||| S:1337 E:1343 ||| VBN
in  ||| S:1343 E:1346 ||| IN
5  ||| S:1346 E:1348 ||| CD
regions  ||| S:1348 E:1356 ||| NNS
of  ||| S:1356 E:1359 ||| IN
the  ||| S:1359 E:1363 ||| DT
PvAMA-1  ||| S:1363 E:1371 ||| NN
with  ||| S:1371 E:1376 ||| IN
10  ||| S:1376 E:1379 ||| CD
mutation  ||| S:1379 E:1388 ||| NN
sites  ||| S:1388 E:1394 ||| NNS
( ||| S:1394 E:1395 ||| -LRB-
E145A ||| S:1395 E:1400 ||| NNP
,  ||| S:1400 E:1402 ||| ,
K188N ||| S:1402 E:1407 ||| NNP
,  ||| S:1407 E:1409 ||| ,
E189N ||| S:1409 E:1414 ||| NNP
/ ||| S:1414 E:1415 ||| NNP
K ||| S:1415 E:1416 ||| NNP
/ ||| S:1416 E:1417 ||| NNP
D ||| S:1417 E:1418 ||| NNP
,  ||| S:1418 E:1420 ||| ,
K190Q ||| S:1420 E:1425 ||| NNP
/ ||| S:1425 E:1426 ||| NNP
E ||| S:1426 E:1427 ||| NNP
,  ||| S:1427 E:1429 ||| ,
P210S ||| S:1429 E:1434 ||| NNP
,  ||| S:1434 E:1436 ||| ,
E227V ||| S:1436 E:1441 ||| NNP
,  ||| S:1441 E:1443 ||| ,
D242E ||| S:1443 E:1448 ||| NNP
,  ||| S:1448 E:1450 ||| ,
R249H ||| S:1450 E:1455 ||| NNP
,  ||| S:1455 E:1457 ||| ,
G253E ||| S:1457 E:1462 ||| NNP
,  ||| S:1462 E:1464 ||| ,
K352E ||| S:1464 E:1469 ||| CD
) ||| S:1469 E:1470 ||| -RRB-
,  ||| S:1470 E:1472 ||| ,
whereas  ||| S:1472 E:1480 ||| IN
only  ||| S:1480 E:1485 ||| RB
one  ||| S:1485 E:1489 ||| CD
mutation  ||| S:1489 E:1498 ||| NNS
( ||| S:1498 E:1499 ||| -LRB-
G288E ||| S:1499 E:1504 ||| NNP
)  ||| S:1504 E:1506 ||| -RRB-
has  ||| S:1506 E:1510 ||| VBZ
been  ||| S:1510 E:1515 ||| VBN
detected  ||| S:1515 E:1524 ||| VBN
in  ||| S:1524 E:1527 ||| IN
intrinsically  ||| S:1527 E:1541 ||| FW
unstructured ||| S:1541 E:1553 ||| FW
/ ||| S:1553 E:1554 ||| FW
disordered  ||| S:1554 E:1565 ||| FW
regions ||| S:1565 E:1572 ||| FW
.  ||| S:1572 E:1574 ||| .
Fixation  ||| S:1574 E:1583 ||| JJ
index  ||| S:1583 E:1589 ||| NN
( ||| S:1589 E:1590 ||| -LRB-
Fst ||| S:1590 E:1593 ||| NNP
)  ||| S:1593 E:1595 ||| -RRB-
estimation  ||| S:1595 E:1606 ||| NN
between  ||| S:1606 E:1614 ||| IN
Iranian  ||| S:1614 E:1622 ||| JJ
and  ||| S:1622 E:1626 ||| CC
Indian  ||| S:1626 E:1633 ||| JJ
isolates  ||| S:1633 E:1642 ||| NNS
( ||| S:1642 E:1643 ||| -LRB-
0.0131 ||| S:1643 E:1649 ||| NNP
)  ||| S:1649 E:1651 ||| -RRB-
indicated  ||| S:1651 E:1661 ||| VBD
a  ||| S:1661 E:1663 ||| DT
significant  ||| S:1663 E:1675 ||| JJ
low  ||| S:1675 E:1679 ||| JJ
genetic  ||| S:1679 E:1687 ||| JJ
differentiation ||| S:1687 E:1702 ||| NN
.  ||| S:1702 E:1704 ||| .
Distribution  ||| S:1704 E:1717 ||| NN
of  ||| S:1717 E:1720 ||| IN
the  ||| S:1720 E:1724 ||| DT
polymorphic  ||| S:1724 E:1736 ||| JJ
sites  ||| S:1736 E:1742 ||| NNS
and  ||| S:1742 E:1746 ||| CC
IURs  ||| S:1746 E:1751 ||| JJ
mapped  ||| S:1751 E:1758 ||| NN
on  ||| S:1758 E:1761 ||| IN
a  ||| S:1761 E:1763 ||| DT
three  ||| S:1763 E:1769 ||| CD
dimensional  ||| S:1769 E:1781 ||| JJ
structure  ||| S:1781 E:1791 ||| NN
of  ||| S:1791 E:1794 ||| IN
PvAMA-1  ||| S:1794 E:1802 ||| NNP
showed  ||| S:1802 E:1809 ||| VBD
that  ||| S:1809 E:1814 ||| IN
these  ||| S:1814 E:1820 ||| DT
regions  ||| S:1820 E:1828 ||| NNS
were  ||| S:1828 E:1833 ||| VBD
located  ||| S:1833 E:1841 ||| VBN
at  ||| S:1841 E:1844 ||| IN
two  ||| S:1844 E:1848 ||| CD
opposite  ||| S:1848 E:1857 ||| NN
faces  ||| S:1857 E:1863 ||| VBZ
of  ||| S:1863 E:1866 ||| IN
the  ||| S:1866 E:1870 ||| DT
molecule ||| S:1870 E:1878 ||| NN
.  ||| S:1878 E:1880 ||| .
In  ||| S:1880 E:1883 ||| IN
conclusion ||| S:1883 E:1893 ||| NN
,  ||| S:1893 E:1895 ||| ,
the  ||| S:1895 E:1899 ||| DT
results  ||| S:1899 E:1907 ||| NNS
have  ||| S:1907 E:1912 ||| VBP
significant  ||| S:1912 E:1924 ||| JJ
value  ||| S:1924 E:1930 ||| NN
in  ||| S:1930 E:1933 ||| IN
the  ||| S:1933 E:1937 ||| DT
design  ||| S:1937 E:1944 ||| NN
and  ||| S:1944 E:1948 ||| CC
development  ||| S:1948 E:1960 ||| NN
of  ||| S:1960 E:1963 ||| IN
a  ||| S:1963 E:1965 ||| DT
malaria  ||| S:1965 E:1973 ||| JJ
vaccine  ||| S:1973 E:1981 ||| NN
based  ||| S:1981 E:1987 ||| VBN
on  ||| S:1987 E:1990 ||| IN
this  ||| S:1990 E:1995 ||| DT
antigen ||| S:1995 E:2002 ||| NN
.  ||| S:2002 E:2004 ||| .
